Jaeik Oh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jaeik Oh has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Hae Rim Jung
Medical Research Center, Genomic Medicine Institute, Seoul National University College of Medicine, Seoul, Republic of Korea
17 shared publications - Jiwon Kim
Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea
17 shared publications - Seungjae Shin
Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea
17 shared publications - Soo-Jin Lee
Seoul National University College of Medicine
17 shared publications - Sung-Yup Cho
Department of Biochemistry and Molecular Biology, Seoul National University College of Medicine, Seoul, Republic of Korea
17 shared publications - Yoojin Yang
Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea
17 shared publications
Latest Publications
- Open Access
- 15 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Fig.S3 from KRAS Mutations Reprogram RNA m6A Modifications to Drive CD73-Dependent Immune Evasion in Colorectal Cancer
Locus-specific regulation of CD73 m6A methylation decreases its expression
- 15 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig.S3 from KRAS Mutations Reprogram RNA m6A Modifications to Drive CD73-Dependent Immune Evasion in Colorectal Cancer
Locus-specific regulation of CD73 m6A methylation decreases its expression
- Open Access
- 15 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Fig.S2 from KRAS Mutations Reprogram RNA m6A Modifications to Drive CD73-Dependent Immune Evasion in Colorectal Cancer
KRAS mutation and MAPK signaling increase CD73 expression
- 15 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig.S2 from KRAS Mutations Reprogram RNA m6A Modifications to Drive CD73-Dependent Immune Evasion in Colorectal Cancer
KRAS mutation and MAPK signaling increase CD73 expression
- Open Access
- 15 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Fig.S1 from KRAS Mutations Reprogram RNA m6A Modifications to Drive CD73-Dependent Immune Evasion in Colorectal Cancer
Characterization of the m 6 A landscape associated with KRAS
- 15 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig.S1 from KRAS Mutations Reprogram RNA m6A Modifications to Drive CD73-Dependent Immune Evasion in Colorectal Cancer
Characterization of the m 6 A landscape associated with KRAS
- Open Access
- 15 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Fig.S10 from KRAS Mutations Reprogram RNA m6A Modifications to Drive CD73-Dependent Immune Evasion in Colorectal Cancer
The KRAS-METTL3-CD73 axis is associated with CD73-high malignant cell states in human CRC
- 15 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig.S10 from KRAS Mutations Reprogram RNA m6A Modifications to Drive CD73-Dependent Immune Evasion in Colorectal Cancer
The KRAS-METTL3-CD73 axis is associated with CD73-high malignant cell states in human CRC
- Open Access
- 15 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Fig.S6 from KRAS Mutations Reprogram RNA m6A Modifications to Drive CD73-Dependent Immune Evasion in Colorectal Cancer
The METTL3-CD73 axis attenuates human CD8+ T-cell effector function
- 15 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig.S6 from KRAS Mutations Reprogram RNA m6A Modifications to Drive CD73-Dependent Immune Evasion in Colorectal Cancer
The METTL3-CD73 axis attenuates human CD8+ T-cell effector function
- Open Access
- 15 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Fig.S7 from KRAS Mutations Reprogram RNA m6A Modifications to Drive CD73-Dependent Immune Evasion in Colorectal Cancer
The KRAS-METTL3-CD73 axis regulates tumor growth and tumor immune remodeling
- 15 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig.S7 from KRAS Mutations Reprogram RNA m6A Modifications to Drive CD73-Dependent Immune Evasion in Colorectal Cancer
The KRAS-METTL3-CD73 axis regulates tumor growth and tumor immune remodeling
- Open Access
- 15 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Fig.S4 from KRAS Mutations Reprogram RNA m6A Modifications to Drive CD73-Dependent Immune Evasion in Colorectal Cancer
IGF2BP3 regulates CD73 expression as an m6A reader protein
- 15 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig.S4 from KRAS Mutations Reprogram RNA m6A Modifications to Drive CD73-Dependent Immune Evasion in Colorectal Cancer
IGF2BP3 regulates CD73 expression as an m6A reader protein
- Open Access
- 15 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Fig.S5 from KRAS Mutations Reprogram RNA m6A Modifications to Drive CD73-Dependent Immune Evasion in Colorectal Cancer
TEAD4 is a binding partner of the methyltransferase complex
- 15 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig.S5 from KRAS Mutations Reprogram RNA m6A Modifications to Drive CD73-Dependent Immune Evasion in Colorectal Cancer
TEAD4 is a binding partner of the methyltransferase complex
- Open Access
- 15 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from KRAS Mutations Reprogram RNA m6A Modifications to Drive CD73-Dependent Immune Evasion in Colorectal Cancer
Supplementary Table S1 from KRAS Mutations Reprogram RNA m6A Modifications to Drive CD73-Dependent Immune Evasion in Colorectal Cancer
- 15 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from KRAS Mutations Reprogram RNA m6A Modifications to Drive CD73-Dependent Immune Evasion in Colorectal Cancer
Supplementary Table S1 from KRAS Mutations Reprogram RNA m6A Modifications to Drive CD73-Dependent Immune Evasion in Colorectal Cancer
- Open Access
- 15 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from KRAS Mutations Reprogram RNA m6A Modifications to Drive CD73-Dependent Immune Evasion in Colorectal Cancer
List of m6A peaks for each sample, related to Figure 1
- 15 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from KRAS Mutations Reprogram RNA m6A Modifications to Drive CD73-Dependent Immune Evasion in Colorectal Cancer
List of m6A peaks for each sample, related to Figure 1